← back to dashboard

ACAD

ACADIA PHARMACEUTICALS INC
Composite
0.05
EDGAR
0.05
Filings (90d)
2
Peak
0.12
Last Signal
2026-09-11T17:15

All Filings

Filed Form Items Signal Score Summary Link
2026-09-11 17:15 8-K ["8.01", "9.01"] other 0.05 Routine stockholder derivative settlement approval; no M&A relevance. SEC · detail
2026-08-04 16:16 8-K ["2.02", "9.01"] other 0.05 Routine 8-K reporting H1 2026 financial results; no M&A signals present. SEC · detail
2026-05-29 16:05 8-K ["5.02", "5.07", "9.01"] other 0.05 Routine annual meeting with director elections, equity plan amendment, and auditor ratification. No M&A signals. SEC · detail
2026-05-06 16:50 8-K ["2.02", "9.01"] other 0.05 Routine quarterly earnings announcement with no M&A indicators. SEC · detail
2026-04-30 17:34 8-K ["5.02", "7.01", "9.01"] officer change 0.25 Head of R&D retirement announcement; no M&A signals. Planned departure for personal reasons with transition plan. SEC · detail